SignalCorporate

BIONANO GENOMICS PRESENTS OGM CLINICAL & FINANCIAL UPDATE; Q2 REVENUE $8.2M, FY27 REV OUTLOOK $50–54M - TRADINGVIEW - GNEWS

Q2 revenue $8.2M and FY27 outlook $50–54M drive clinical and financial update.

What changed

Q2 revenue $8.2M and FY27 outlook $50–54M drive clinical and financial update.

Why it matters

Q2 revenue $8.2M and FY27 outlook $50–54M drive clinical and financial update. — impact context not separately stored; see What changed.

Sources